CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $30,370
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-16 | Sander Dale A. CFO and Chief Corp. Deve. Off. | Grant or award | +311,100 | 313,100 | ||
| 2025-11-16 | Parikh Shamik J Chief Medical Officer | Grant or award | +311,100 | 318,600 | ||
| 2025-11-16 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +311,100 | 311,100 | ||
| 2025-11-16 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +311,100 | 311,100 | ||
| 2025-08-20 | Dougan Brady W Director | Sale | −591,685 | $1.58 | $935K | 0 |
| 2025-08-20 | Niklason Laura E President, CEO and Director | Sale | −591,685 | $1.58 | $935K | 0 |
| 2025-08-19 | Dougan Brady W Director | Sale | −1,100,000 | $1.63 | $1.8M | 591,685 |
| 2025-08-19 | Niklason Laura E President, CEO and Director | Sale | −1,100,000 | $1.63 | $1.8M | 591,685 |
| 2025-08-18 | Dougan Brady W Director | Sale | −549,360 | $1.83 | $1.0M | 1,691,685 |
| 2025-08-18 | Niklason Laura E President, CEO and Director | Sale | −549,360 | $1.83 | $1.0M | 1,691,685 |
| 2025-06-12 | Pope Todd Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2025-06-12 | Brown Emery N. Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2025-06-12 | Jones Keith Anthony Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2025-06-12 | Wallace Max N. Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2025-06-12 | Windham-Bannister Susan Richards Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2025-06-12 | Niklason Laura E President, CEO and Director | Grant or award · Stock Options (right to buy) | +0 | 0 | ||
| 2025-06-12 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +0 | 0 | ||
| 2025-06-12 | Green Charles Bruce Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2025-06-12 | Constantino Michael T. Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 | ||
| 2025-06-12 | Bamforth John Philip Director | Grant or award · Stock Options (right to buy) | +80,000 | 80,000 |
Page 2 of 17 · 330 trades